生物谷
(833266)
| 流通市值：8.15亿 | | | 总市值：12.98亿 |
| 流通股本：7785.52万 | | | 总股本：1.24亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 92,118,348.63 | 516,232,107.07 | 420,136,311.75 | 288,102,917.17 |
| 营业收入 | 92,118,348.63 | 516,232,107.07 | 420,136,311.75 | 288,102,917.17 |
| 二、营业总成本 | 109,835,302.62 | 537,883,852.27 | 413,228,498.54 | 276,423,111.01 |
| 营业成本 | 44,564,931.5 | 139,940,745.88 | 99,270,136.57 | 64,707,860.14 |
| 税金及附加 | 1,678,595.71 | 10,106,151.48 | 7,947,952.82 | 5,337,035.49 |
| 销售费用 | 41,948,563.62 | 280,722,395.7 | 249,985,366.04 | 172,855,093.11 |
| 管理费用 | 18,220,315.97 | 93,412,243.69 | 46,395,822.12 | 26,858,065.93 |
| 研发费用 | 3,106,530.71 | 13,188,627.91 | 9,208,001.89 | 6,111,684.85 |
| 财务费用 | 316,365.11 | 513,687.61 | 421,219.1 | 553,371.49 |
| 其中:利息费用 | 541,774.36 | 2,726,573.61 | 2,160,758.39 | 1,525,229.95 |
| 其中:利息收入 | 233,517.96 | 2,233,095.29 | 1,755,030.05 | 981,172.9 |
| 加:公允价值变动收益 | - | 837,201.82 | 124,026.71 | 124,026.71 |
| 加:投资收益 | 50,213.03 | 511,555.11 | 447,686.62 | 447,686.62 |
| 资产处置收益 | -2,093.73 | -2,238.68 | 79,592 | 80,079.43 |
| 资产减值损失(新) | -485,081.64 | -1,234,550 | -632,544.81 | -312,472.34 |
| 信用减值损失(新) | -368,158.34 | -61,301,650.4 | -8,657,613.09 | -8,662,533.23 |
| 其他收益 | 2,280,056.12 | 7,242,168.73 | 4,822,791.26 | 3,383,969.46 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -16,242,018.55 | -75,599,258.62 | 3,091,751.9 | 6,740,562.81 |
| 加:营业外收入 | 274.05 | 196,730.58 | 0.32 | 0.32 |
| 减:营业外支出 | 50,183.75 | 2,037,173.01 | 337,319.18 | 405,473.15 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -16,291,928.25 | -77,439,701.05 | 2,754,433.04 | 6,335,089.98 |
| 减:所得税费用 | 476,275.58 | -3,038,736.14 | 963,916.76 | 1,533,398.84 |
| 六、净利润 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 | 4,801,691.14 |
| 持续经营净利润 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 | - |
| 归属于母公司股东的净利润 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 | 4,801,691.14 |
| (一)基本每股收益 | -0.14 | -0.6 | 0.01 | 0.04 |
| (二)稀释每股收益 | - | -0.6 | 0.01 | 0.04 |
| 九、综合收益总额 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 | 4,801,691.14 |
| 归属于母公司股东的综合收益总额 | - | -74,400,964.91 | 1,790,516.28 | 4,801,691.14 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-26 |
| 审计意见(境内) | | 保留意见 | | |